Actinium Pharmaceuticals, Inc. Investors Urged to Seek Guidance Amid Securities Class Action Deadline Approaching
Rosen, a leading law firm, encourages Actinium Pharmaceuticals investors to secure counsel before the March 25 deadline to file a lead plaintiff motion in the securities class action lawsuit.